The board of directors of Utah Medical Products (NasdaqGS:UTMD) on Tuesday declared a quarterly dividend of USD0.26 per share of the company's common stock.

Shareholders of record at the close of business as of 17 June 2016 will receive the cash dividend on 6 July 2016.

This marks a growth of 2% from the dividend declared in the same quarter of the prior year.

With particular interest in health care for women and their babies, the company develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in hundreds of countries around the world as the standard for obtaining optimal long term outcomes for their patients.